Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for fetal growth restriction
IRCT20140317017034N9Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of pentoxifylline in intrauterine growth restriction (IUGR) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Umbilical artery Doppler, Uterine artery Doppler and 4 more. Started Nov 2019; status: completed.
02
Drugs
pentoxifylline
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20140317017034N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140317017034N9.